Skip to content
The Nexus
DossierENTITY

Institute of Cancer Research

Coverage of Institute of Cancer Research in the Nexus archive.

Earliest in view: Apr 13 · 09:00 UTCMost recent: Jun 2 · 17:00 UTC
Co-mentioned in this coverage
Durvalumabtopic1bladder cancertopic1Londonplace1PhenMaptopic1RCSI University of Medicine and Health Sciencesorganization1NHSorganization1Bowel cancertopic1
Recent coverage
  • HEALTHJun 2 · 17:00 UTCTHE GUARDIAN WORLD
    Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery

    Doctors are praising the drug Durvalumab for its ability to prevent bladder cancer tumors from returning and avoid life-changing surgery. A trial led by the London-based Institute of Cancer Research showed promising results for the treatment.

  • HEALTHApr 13 · 09:00 UTCTHE GUARDIAN WORLD
    AI to predict how bowel cancer patients will respond to new NHS drug

    An AI tool called PhenMap has been developed to predict how advanced bowel cancer patients will respond to a new NHS drug, aiming to avoid ineffective treatments. Researchers from the Institute of Cancer Research and RCSI University of Medicine and Health Sciences collaborated on this method to improve patient outcomes.